Speaker Profile
Jagdish Suri

Jagdish Suri DTCD, MD, DNB, FNCCP

Critical Care Medicine, Sleep Medicine, Pulmonary Medicine
New Delhi, Delhi, India

Connect with the speaker?

Dr. Jagdish Chander Suri is one of the eminent pulmonologists, Critical Care & Sleep Medicine experts with over 35 yrs of experience in this field. He was a former Consultant, Professor, and Head of the Department of Pulmonary, Critical Care, and Sleep Medicine at Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India. He is a recognized DM and MD postgraduate guide for the University of Delhi, GGS IP University, Delhi, and the National Board of Examination for the last 30 years. He is credited with introducing the field of clinical sleep medicine in India and establishing the first state-of-the-art sleep lab in India at Safdarjang Hospital in 1990. He also established the first critical care unit under Physician care exclusively in North India in 1990 and went on to establish the first comprehensive Department of Pulmonary, Critical Care, and Sleep Medicine in India at Safdarjang Hospital. He started the DM program in Pulmonary and Critical Care Medicine at VMMC and Safdarjang Hospital, the second such center in India to do so. As Vice Principal of VMMC, he was instrumental in developing the course and curriculum for the MBBS students at GGS IP University. Dr Suri has many contributions towards Govt. of India's National programs where his aid started back in 1994 as an expert for the development of the National TB Control Program. He is an advisor for the development of guidelines for virus outbreaks such as H1N1, and COVID-19.Dr. Suri has trained many leading Pulmonologists and Intensivists in India. He was actively involved as an expert in the development of guidelines for COPD, CPAP, BiPAP, and Oxygen concentrators for the beneficiaries of the Central Govt. Health Schemes. Dr. Suri is also the National advisor for the pulmonary group at the Drug Controller General India for the screening of new proposals for drug trials submitted by various pharmaceutical companies.